San Francisco Cancer Initiative Identifies 1st Year Progress, Challenges

Scientists behind the San Francisco Cancer Initiative (SF CAN) have published their first paper, which describes the project’s early progress, including forging collaborations with more than 40 community organizations and other key stakeholders. The paper also presents a framework for other cities on how to systematically plan and develop a similar structure for community-based health projects. Robert A. Hiatt, MD, PhD, professor in the Department of Epidemiology and Biostatistics, is first author on the paper.

SF CAN is targeting the five most common cancers which collectively account for half of all new cancers in San Francisco: breast, lung and other tobacco-related cancers, prostate, colorectal and liver cancer.

Read the full story at or read the paper in Health Affairs.